Essais cliniques

• Solstice

Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

• ORPHAVIC

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.

• QUANTIC R+

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test

• PHRC CMV

Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients

• CrechMV

Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France

•  CYMEPEDIA

Previous Study | Return to List | Next Study Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero

• CYMEVAL I

In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir

• CYMEVAL II

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir

• CYMEVAL III STEP 1
  

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir – STEP 1

• CymeAUdit

Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening

• TransfeCMV

Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant

• PRIOH-1

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects